ABEV vs. DEO, KDP, STZ, BF.B, COCO, BRCC, WEST, NAPA, WVVI, and VWE
Should you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Diageo (DEO), Keurig Dr Pepper (KDP), Constellation Brands (STZ), Brown-Forman (BF.B), Vita Coco (COCO), BRC (BRCC), Westrock Coffee (WEST), Duckhorn Portfolio (NAPA), Willamette Valley Vineyards (WVVI), and Vintage Wine Estates (VWE). These companies are all part of the "beverages" industry.
Diageo (NYSE:DEO) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking.
Ambev received 82 more outperform votes than Diageo when rated by MarketBeat users. Likewise, 60.48% of users gave Ambev an outperform vote while only 59.19% of users gave Diageo an outperform vote.
Diageo has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Ambev has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500.
9.0% of Diageo shares are held by institutional investors. Comparatively, 8.1% of Ambev shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Diageo pays an annual dividend of $3.22 per share and has a dividend yield of 2.4%. Ambev pays an annual dividend of $0.25 per share and has a dividend yield of 11.5%. Ambev pays out 131.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ambev has increased its dividend for 2 consecutive years. Ambev is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Diageo has higher earnings, but lower revenue than Ambev.
Diageo currently has a consensus price target of $166.37, suggesting a potential upside of 22.29%. Ambev has a consensus price target of $2.68, suggesting a potential upside of 23.22%. Given Diageo's stronger consensus rating and higher possible upside, analysts clearly believe Ambev is more favorable than Diageo.
Ambev has a net margin of 18.25% compared to Ambev's net margin of 0.00%. Diageo's return on equity of 17.53% beat Ambev's return on equity.
In the previous week, Diageo had 5 more articles in the media than Ambev. MarketBeat recorded 9 mentions for Diageo and 4 mentions for Ambev. Diageo's average media sentiment score of 1.11 beat Ambev's score of 1.01 indicating that Ambev is being referred to more favorably in the news media.
Summary
Ambev beats Diageo on 13 of the 18 factors compared between the two stocks.
Get Ambev News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
